share_log

7 Analysts Have This To Say About Abbott Laboratories

7 Analysts Have This To Say About Abbott Laboratories

7位分析师对雅培公司的评论
Benzinga ·  07/02 11:02
Analysts' ratings for Abbott Laboratories (NYSE:ABT) over the last quarter vary from bullish to bearish, as provided by 7 analysts.
在过去的季度,7位分析师对雅培(NYSE:ABT)的评级从看好到看淡不一。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级概况,突出了过去30天内情绪的变化,并将其与之前的月份进行了比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $125.0, along with a high estimate of $140.00 and a low estimate of $119.00. This current average has decreased by 2.21% from the previous average price target of $127.83.
此外,分析师们建立了12个月的价格目标,平均目标为125.0美元,高估值为140.00美元,低估值为119.00美元。与之前的平均目标价相比,这个目标价平均数下降了2.21%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析师评级解读:深入分析
A comprehensive examination of how financial experts perceive Abbott...
通过分析师的行为,...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发